IMM — ImmuPharma Balance Sheet
0.000.00%
- £10.10m
- £9.01m
Annual balance sheet for ImmuPharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.36 | 5.86 | 1.65 | 0.668 | 0.208 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.709 | 0.482 | 1.13 | 1.34 | 0.686 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.58 | 7.43 | 3.35 | 2.34 | 1.34 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.207 | 0.412 | 0.353 | 0.39 | 0.102 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 5.8 | 10.9 | 6 | 3.97 | 2.72 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 0.532 | 1.26 | 1.58 | 1.45 | 1.67 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.532 | 1.26 | 1.58 | 1.45 | 1.67 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5.27 | 9.65 | 4.41 | 2.52 | 1.06 |
Total Liabilities & Shareholders' Equity | 5.8 | 10.9 | 6 | 3.97 | 2.72 |
Total Common Shares Outstanding |